Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Delayed Quote USD

Sotera Health Company (SHC)

Compare
11.13
-0.53
(-4.55%)
At close: April 1 at 4:00:00 PM EDT
11.17
+0.04
+(0.36%)
After hours: April 1 at 4:26:05 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 290.2M
Earnings 12.32M

Q1'24

Q2'24

Q3'24

Q4'24

0
100M
200M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

13.00
15.07 Average
11.13 Current
17.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 8887
Avg. Estimate 0.120.180.740.84
Low Estimate 0.110.180.720.81
High Estimate 0.130.190.780.89
Year Ago EPS 0.130.190.70.74

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 7777
Avg. Estimate 245.56M281.07M1.13B1.2B
Low Estimate 242M278.82M1.12B1.19B
High Estimate 249.22M286.95M1.13B1.21B
Year Ago Sales 248.18M276.59M1.1B1.13B
Sales Growth (year/est) -1.05%1.62%2.68%5.82%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 0.120.160.180.2
EPS Actual 0.130.190.170.21
Difference 0.010.03-0.010.01
Surprise % 5.01%15.21%-7.01%4.02%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.120.180.740.84
7 Days Ago 0.120.180.740.84
30 Days Ago 0.140.20.780.89
60 Days Ago 0.140.20.790.89
90 Days Ago 0.140.20.790.9

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----11
Up Last 30 Days ----11
Down Last 7 Days 6487
Down Last 30 Days 6487

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SHC -5.42%-3.10%5.57%13.85%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Maintains Barclays: Overweight to Overweight 2/28/2025
Maintains Barclays: Overweight to Overweight 2/18/2025
Reiterates RBC Capital: Outperform to Outperform 11/21/2024
Maintains Citigroup: Buy to Buy 11/6/2024
Maintains Barclays: Overweight to Overweight 8/6/2024
Reiterates RBC Capital: Outperform to Outperform 8/6/2024

Related Tickers

QGEN Qiagen N.V.
39.50
-1.62%
 
MYGN Myriad Genetics, Inc.
8.84
-0.34%
 
MTD Mettler-Toledo International Inc.
1,156.38
-2.08%
 
CRL Charles River Laboratories International, Inc.
145.99
-3.01%
 
IDXG Interpace Biosciences, Inc.
0.9490
-0.01%
 
GH Guardant Health, Inc.
42.47
-0.31%
 
RVTY Revvity, Inc.
104.31
-1.41%
 
ARYC Arrayit Corporation
0.0001
0.00%
 
AVCRF Avricore Health Inc.
0.0388
+17.58%
 
LZAGF Lonza Group AG
598.90
0.00%